甾体激素与子宫内膜异位症  

Steroid hormone and endometriosis

作　　者：郝群[1] 梁元姣[1] 

机构地区：[1]南京军区南京总医院妇产科,南京医学博士210002

出　　处：《医学研究生学报》2012年第5期524-528,共5页Journal of Medical Postgraduates

基　　金：南京军区2008年科技创新项目(08MA092)

摘　　要：子宫内膜异位症(endometriosis,EMS)是指有生长功能的子宫内膜出现在子宫腔被覆黏膜以外的身体的其他部位而引起的疾病。EMS发病率近年明显升高,约为5%～10%,此病虽属良性疾病却表现类似恶性行为,其病因及发病机制尚不清楚,而且缺乏有效的治疗手段。EMS是一种雌激素依赖性疾病,甾体激素相关治疗已证实是有效的。文中就近年来对EMS发病机制中的甾体激素基础研究进展作一综述。Endometriosis is the presence of endometrial tissue that normally grows inside the uterus in an abnormal anatomical location. The incidence of endometriosis increases sharply in recent years, its etiology and pathogenesis are not well-understood till now and effective treatment is absent. Endometriosis is an estrogen-dependent disease and steroid hormone related therapy has been demon- strated effective. In this review, we focus on the basic research advancement of steroid hormone in pathogenesis of endometriosis.

关 键 词：子宫内膜异位症 甾体激素 

分 类 号：R730[医药卫生—肿瘤]